Literature DB >> 14985790

Gene therapy progress and prospects: transcription regulatory systems.

C Toniatti1, H Bujard, R Cortese, G Ciliberto.   

Abstract

The clinical efficacy and safety as well as the application range of gene therapy will be broadened by developing systems capable of finely modulating the expression of therapeutic genes. Transgene regulation will be crucial for maintaining appropriate levels of a gene product within the therapeutic range, thus preventing toxicity. Moreover, the possibility to modulate, stop or resume transgene expression in response to disease evolution would facilitate the combination of gene therapy with more conventional therapeutic modalities. The development of ligand-dependent transcription regulatory systems is thus of great importance. Here, we summarize the most recent progress in the field.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14985790     DOI: 10.1038/sj.gt.3302251

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  32 in total

1.  Establishment of a cellular model to study TrkC-dependent neuritogenesis.

Authors:  Pawel Krawczyk; Ewa Twarog; Ewa Kurowska; Dagmara Klopotowska; Janusz Matuszyk
Journal:  In Vitro Cell Dev Biol Anim       Date:  2014-11-15       Impact factor: 2.416

2.  Drug-inducible and simultaneous regulation of endogenous genes by single-chain nuclear receptor-based zinc-finger transcription factor gene switches.

Authors:  L Magnenat; L J Schwimmer; C F Barbas
Journal:  Gene Ther       Date:  2008-06-05       Impact factor: 5.250

3.  Applying an Inducible Expression System to Study Interference of Bacterial Virulence Factors with Intracellular Signaling.

Authors:  Christian Berens; Stephanie Bisle; Leonie Klingenbeck; Anja Lührmann
Journal:  J Vis Exp       Date:  2015-06-25       Impact factor: 1.355

Review 4.  Improving miRNA Delivery by Optimizing miRNA Expression Cassettes in Diverse Virus Vectors.

Authors:  Elena Herrera-Carrillo; Ying Poi Liu; Ben Berkhout
Journal:  Hum Gene Ther Methods       Date:  2017-08       Impact factor: 2.396

Review 5.  Viral expression cassette elements to enhance transgene target specificity and expression in gene therapy.

Authors:  Sara Kathleen Powell; Ricardo Rivera-Soto; Steven James Gray
Journal:  Discov Med       Date:  2015-01       Impact factor: 2.970

Review 6.  A next step in adeno-associated virus-mediated gene therapy for neurological diseases: regulation and targeting.

Authors:  Abdelwahed Chtarto; Olivier Bockstael; Terence Tshibangu; Olivier Dewitte; Marc Levivier; Liliane Tenenbaum
Journal:  Br J Clin Pharmacol       Date:  2013-08       Impact factor: 4.335

Review 7.  Design and implementation of adoptive therapy with chimeric antigen receptor-modified T cells.

Authors:  Michael C Jensen; Stanley R Riddell
Journal:  Immunol Rev       Date:  2014-01       Impact factor: 12.988

8.  Effect of elongation factor 1alpha promoter and SUMF1 over in vitro expression of N-acetylgalactosamine-6-sulfate sulfatase.

Authors:  Carlos J Alméciga-Díaz; Maria A Rueda-Paramo; Angela J Espejo; Olga Y Echeverri; Adriana Montaño; Shunji Tomatsu; Luis A Barrera
Journal:  Mol Biol Rep       Date:  2008-11-07       Impact factor: 2.316

9.  Characterization of a molecular switch system that regulates gene expression in mammalian cells through a small molecule.

Authors:  Jennifer L Taylor; Priyanka Rohatgi; H Trent Spencer; Donald F Doyle; Bahareh Azizi
Journal:  BMC Biotechnol       Date:  2010-02-18       Impact factor: 2.563

10.  Regulation of boundary cap neural crest stem cell differentiation after transplantation.

Authors:  Hakan Aldskogius; Christian Berens; Nadezda Kanaykina; Anna Liakhovitskaia; Alexander Medvinsky; Martin Sandelin; Silke Schreiner; Michael Wegner; Jens Hjerling-Leffler; Elena N Kozlova
Journal:  Stem Cells       Date:  2009-07       Impact factor: 6.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.